Early cardioprotection with carvedilol and candesartan did not add benefit in preserving CV function in high-risk patients undergoing chemotherapy. Results were similar among those deemed lower-risk.
High-sensitivity cardiac troponin testing can identify patients with stable coronary artery disease who have a greater risk for MI or cardiovascular death, a study conducted in Scotland indicates.
Danicamtiv is an investigational selective agonist of cardiac myosin, intended to help myocyte contraction by enhancing ...
The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
A retrospective review of pegylated liposomal doxorubicin (PLD), bortezomib, and dexamethasone (DVD) for relapsed or refractory (R/R) multiple myeloma (MM) ...
Relying on the sex-specific 99th percentile upper reference limit of cardiac troponin may incorrectly suggest myocardial infarction (MI) in older adults with suspected heart attacks, though no ...
NT-pro-BNP and cTnT as markers for subclinical early-onset anthracycline-induced cardiotoxicity in children: A prospective study. Background: The use of doxorubicin to treat solid and hematological ...
Please provide your email address to receive an email when new articles are posted on . Troponin kinetics can be used to detect hemorrhagic MI after PCI for STEMI. Hemorrhagic MI is linked to elevated ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Hospitalized COVID-19 patients with high troponin levels are twice as likely to have cardiac ...
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback